Clinical Trials Directory

Trials / Unknown

UnknownNCT01441739

Intestinal Failure in Necrotising Enterocolitis

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Necrotizing enterocolitis (NEC) is a severe gastrointestinal disorder with high morbidity and mortality (20-40%), affecting predominantly premature neonates. NEC continues to present a diagnostic challenge to clinicians. The initial clinical manifestations of NEC are non-specific and indistinguishable from other gastrointestinal disorders and sepsis. The first goal of this study is to find and evaluate tests to diagnose NEC at an early stage. For the development of new diagnostic markers, the investigators require knowledge of pathophysiological processes that underlie NEC, which still remain unclear. Therefore, the second goal of this study is to elucidate the etiology of NEC. Furthermore, understanding of the pathophysiology of NEC can offer the possibility to develop new therapeutical treatments.

Conditions

Timeline

Start date
2004-09-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2011-09-28
Last updated
2013-12-18

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01441739. Inclusion in this directory is not an endorsement.